Literature DB >> 32259582

Online survey about the STROBE statement highlighted diverging views about its content, purpose, and value.

Melissa K Sharp1, Ketevan Glonti2, Darko Hren3.   

Abstract

BACKGROUND AND
OBJECTIVE: The endorsement rates of The STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) Statement are low and little is known about authors' opinions about this reporting guideline. We conducted an online survey with observational study authors on attitude toward and experiences with the STROBE Statement with the aim of understanding how to effectively implement STROBE.
METHODS: A thematic analysis on the responses to an open-ended question was conducted using inductive coding. Two coders classified responses independently into themes using a codebook. The inter-rater agreement ranged from 87.7 to 99.9%.
RESULTS: 15% (n = 150) of survey participants (n = 1,015) shared perceptions and insights on STROBE. We established four themes: 1) perceptions of the checklist, 2) academic confidence, 3) use in education and training, and 4) journal endorsement and use in peer review. Views were diverse and revealed multiple misunderstandings about the checklist's purpose and content, and lack of incentives for its use.
CONCLUSIONS: Better communication efforts are needed when disseminating STROBE and other reporting guidelines. These should focus on content, education for early career researchers, and encouragement of critical self-reflection on one's own work. In addition, results emphasized the need for better incentive and enforcement mechanisms.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiologic research design; Guidelines as topic; Information dissemination/methods; Observational studies; STROBE Reporting guidelines

Mesh:

Year:  2020        PMID: 32259582     DOI: 10.1016/j.jclinepi.2020.03.025

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  5 in total

1.  Sleeve lobectomy after neoadjuvant chemoimmunotherapy/chemotherapy for local advanced non-small cell lung cancer.

Authors:  Hengrui Liang; Chao Yang; Diego Gonzalez-Rivas; Yunpeng Zhong; Ping He; Hongsheng Deng; Jun Liu; Wenhua Liang; Jianxing He; Shuben Li
Journal:  Transl Lung Cancer Res       Date:  2021-01

Review 2.  Bayesian Analysis Reporting Guidelines.

Authors:  John K Kruschke
Journal:  Nat Hum Behav       Date:  2021-08-16

3.  Comparative Evaluation of Efficacy and Safety of the Diode Laser (980 nm) and Sclerotherapy in the Treatment of Oral Vascular Malformations.

Authors:  Peeyush Shivhare; Naqoosh Haidry; Neha Sah; Ajay Kumar; Abhishek Gupta; Ankur Singh; Mohan Raju Penumatcha; Shalini Subramanyam
Journal:  Int J Vasc Med       Date:  2022-09-05

4.  Comparative Evaluation of Efficacy and Safety of the Diode Laser (980 nm) and Sclerotherapy for the Treatment of Oral Pyogenic Granuloma.

Authors:  Peeyush Shivhare; Naqoosh Haidry; Neha Sah; Ajay Kumar; Abhishek Gupta; Ankur Singh; Mohan Raju Penumatcha; Shalini Subramanyam
Journal:  Int J Dent       Date:  2022-09-17

5.  One-year mortality and consequences of COVID-19 in cancer patients: A cohort study.

Authors:  Chen Chai; Xiaojun Feng; Meixia Lu; Shoupeng Li; Kui Chen; Hongxiang Wang; Wendan Wang; Zhaoming Tang; Gang Cheng; Xiaoxiong Wu; Yunfeng Li; Yuying Wen; Banghong Da; Hong Fan; Lei Wang; Fen Ai; Wei Li; Cao Peng; Hongrong Zhang; Shuang Wen; Jinnong Zhang; Yuxiong Weng; Zehai Tang
Journal:  IUBMB Life       Date:  2021-08-29       Impact factor: 4.709

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.